🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: SUBPROTOCOL A

Found 59 matching trials

COR-INSIGHT: Optimizing Cardiovascular and Cardiopulmonary Outcomes with AI-Driven Multiplexed Indications Using COR ECG Wearable

N/A

The COR-INSIGHT trial aims to evaluate the effectiveness of Peerbridge COR ...

Status

Enrolling By Invitation

Location

Peerbridge Health, Melbourne, Florida 32935

Start Date

2024-11-16

Trial ID

NCT06763549

Treatments Being Tested

SUBPROTOCOL A SUBPROTOCOL B SUBPROTOCOL C SUBPROTOCOL D SUBPROTOCOL E SUBPROTOCOL F SUBPROTOCOL G SUBPROTOCOL H

Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC

PHASE1

The purpose of this platform study is to evaluate the safety, tolerability,...

Status

Recruiting

Location

Banner MD Anderson Cancer Center

Start Date

2024-01-18

Trial ID

NCT06162221

Treatments Being Tested

RMC-6291 RMC-6236 Pembrolizumab Cisplatin Carboplatin Pemetrexed RMC-9805

Testing Copanlisib as Potentially Targeting Treatment in Cancers With PTEN Loss (MATCH - Subprotocol Z1G)

PHASE2

The phase II MATCH treatment trial tests how well copanlisib works to treat...

Status

Active Not Recruiting

Location

ECOG-ACRIN Cancer Research Group

Start Date

2018-10-08

Trial ID

NCT06360588

Treatments Being Tested

Biopsy Procedure Biospecimen Collection Copanlisib Radiologic Examination

Testing Palbociclib (PD-0332991) as Potentially Targeting Treatment in Cancers With CDK4 or CDK6 Amplification (MATCH - Subprotocol Z1C)

PHASE2

This phase II MATCH treatment trial tests how well palbociclib (PD-0332991)...

Status

Active Not Recruiting

Location

ECOG-ACRIN Cancer Research Group

Start Date

2017-03-22

Trial ID

NCT06390839

Treatments Being Tested

Biopsy Procedure Biospecimen Collection Computed Tomography Magnetic Resonance Imaging Palbociclib

A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease, GM1 Gangliosidosis or GM2 Gangliosidosis

PHASE3

An 18-month double-blind, randomized, placebo-controlled, multicenter, Phas...

Status

Recruiting

Location

UCSF Children's Hospital and Research Center at Oakland

Start Date

2025-06-30

Trial ID

NCT07054515

Treatments Being Tested

AZ-3102 Placebo

AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor

N/A

This prospective, multicenter, cluster-randomized controlled study aims to ...

Status

Recruiting

Location

Orange County Heart Institute

Start Date

2024-11-21

Trial ID

NCT06699056

Treatments Being Tested

15-minutes of sitting during COR ECG Acquistion

Olaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Defects in DNA Damage Repair Genes (A Pediatric MATCH Treatment Trial)

PHASE2

This phase II Pediatric MATCH trial studies how well olaparib works in trea...

Status

Completed

Location

Children's Hospital of Alabama

Start Date

2017-09-14

Trial ID

NCT03233204

Treatments Being Tested

Olaparib

Testing Trametinib as a Potential Targeted Treatment in Cancers With GNAQ or GNA11 Genetic Changes (MATCH-Subprotocol S2)

PHASE2

This phase II MATCH treatment trial identifies the effects of trametinib in...

Status

Active Not Recruiting

Location

ECOG-ACRIN Cancer Research Group

Start Date

2016-02-25

Trial ID

NCT04439357

Treatments Being Tested

Trametinib Dimethyl Sulfoxide

Samotolisib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATCH Treatment Trial)

PHASE2

This phase II Pediatric MATCH trial studies how well samotolisib works in t...

Status

Completed

Location

Children's Hospital of Alabama

Start Date

2017-11-28

Trial ID

NCT03213678

Treatments Being Tested

Biospecimen Collection Computed Tomography FDG-Positron Emission Tomography Magnetic Resonance Imaging Samotolisib X-Ray Imaging

Testing Copanlisib as a Potential Targeted Treatment in Cancers With PIK3CA Mutations (MATCH-Subprotocol Z1F)

PHASE2

This phase II MATCH treatment trial identifies the effects of copanlisib hy...

Status

Active Not Recruiting

Location

ECOG-ACRIN Cancer Research Group

Start Date

2018-06-20

Trial ID

NCT05490771

Treatments Being Tested

Biopsy Procedure Computed Tomography Copanlisib Hydrochloride Magnetic Resonance Imaging

Previous Next